ProShare Advisors
SPPI

ProShare Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

ProShare Advisors’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-15,826
Closed -$7K – 1899
2022
Q3 		$7K Buy
15,826
+1,801
+13% +$1.77K ﹤0.01% 1742
2022
Q2 		$11K Sell
14,025
-33,513
-70% -$29.5K ﹤0.01% 1785
2022
Q1 		$61K Sell
47,538
-16,307
-26% -$15K ﹤0.01% 2100
2021
Q4 		$81K Buy
63,845
+3,669
+6% +$6.56K ﹤0.01% 2228
2021
Q3 		$131K Sell
60,176
-13,419
-18% -$36.7K ﹤0.01% 1870
2021
Q2 		$276K Buy
73,595
+10,549
+17% +$36.7K ﹤0.01% 1949
2021
Q1 		$206K Buy
63,046
+5,773
+10% +$20.7K ﹤0.01% 2024
2020
Q4 		$195K Buy
57,273
+13,476
+31% +$55.5K ﹤0.01% 1853
2020
Q3 		$179K Buy
43,797
+7,595
+21% +$28.9K ﹤0.01% 1434
2020
Q2 		$122K Buy
36,202
+12,283
+51% +$35.8K ﹤0.01% 1544
2020
Q1 		$56K Sell
23,919
-18,730
-44% -$51.3K ﹤0.01% 1112
2019
Q4 		$155K Sell
42,649
-3,454
-7% -$27.9K ﹤0.01% 1641
2019
Q3 		$382K Sell
46,103
-313
-0.7% -$2.53K ﹤0.01% 1097
2019
Q2 		$400K Sell
46,416
-5,308
-10% -$47.5K ﹤0.01% 1107
2019
Q1 		$553K Buy
51,724
+2,024
+4% +$21.7K ﹤0.01% 982
2018
Q4 		$435K Sell
49,700
-8,341
-14% -$106K ﹤0.01% 997
2018
Q3 		$975K Sell
58,041
-1,757
-3% -$38K 0.01% 828
2018
Q2 		$1.25M Sell
59,798
-658
-1% -$12.2K 0.01% 757
2018
Q1 		$973K Sell
60,456
-9,428
-13% -$187K 0.01% 832
2017
Q4 		$1.32M Buy
69,884
+15,454
+28% +$280K 0.01% 739
2017
Q3 		$766K Buy
54,430
+5,219
+11% +$47.2K 0.01% 806
2017
Q2 		$367K Sell
49,211
-4,357
-8% -$28.5K ﹤0.01% 1070
2017
Q1 		$348K Sell
53,568
-13,658
-20% -$76.4K ﹤0.01% 1176
2016
Q4 		$298K Buy
67,226
+7,748
+13% +$32.5K ﹤0.01% 1369
2016
Q3 		$278K Sell
59,478
-1,595
-3% -$9.45K ﹤0.01% 1180
2016
Q2 		$401K Buy
61,073
+1,054
+2% +$7.45K 0.01% 1064
2016
Q1 		$382K Sell
60,019
-5,359
-8% -$27.5K 0.01% 1107
2015
Q4 		$394K Buy
65,378
+6,541
+11% +$37.4K ﹤0.01% 1156
2015
Q3 		$352K Sell
58,837
-4,216
-7% -$29.3K ﹤0.01% 1077
2015
Q2 		$431K Sell
63,053
-4,156
-6% -$26.4K 0.01% 1158
2015
Q1 		$408K Buy
67,209
+8,301
+14% +$55.2K ﹤0.01% 1288
2014
Q4 		$408K Sell
58,908
-2,265
-4% -$16.7K ﹤0.01% 1318
2014
Q3 		$498K Sell
61,173
-12,510
-17% -$97.9K 0.01% 1415
2014
Q2 		$599K Sell
73,683
-40,567
-36% -$308K 0.01% 1469
2014
Q1 		$896K Buy
114,250
+80,811
+242% +$684K 0.01% 1394
2013
Q4 		$296K Sell
33,439
-30,154
-47% -$269K ﹤0.01% 1160
2013
Q3 		$534K Buy
63,593
+11,355
+22% +$91.9K 0.01% 1410
2013
Q2 		$390K Buy
+52,238
New +$401K 0.01% 1514

Other funds holding SPPI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return

ProShare Advisors's SPPI Position: Q4 2022 in Review

ProShare Advisors sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2022, closing a stake of 15,826 shares — an estimated $7K sold.

ProShare Advisors first reported a position in SPPI in Q2 2013 and held it in 38 quarters. The position peaked at $1.32M in Q4 2017. 70 funds tracked by Wall St. Rank hold SPPI as of Q4 2022.

  • ProShare Advisors reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2022 after selling out during the quarter.
  • ProShare Advisors sold 15,826 Spectrum Pharmaceuticals Inc shares in Q4 2022, an estimated $7K.
  • ProShare Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 38 quarters.
  • ProShare Advisors's Spectrum Pharmaceuticals Inc position peaked at $1.32M in Q4 2017.
  • 70 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2022.

Based on ProShare Advisors's 13F filing for Q4 2022, filed 2 Feb 2023.